Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Orion Oyj B (ORNBV)Orion Oyj B stock price live, this page displays HE ORNBV stock exchange data. View the ORNBV premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Orion Oyj B real time stock price chart below.
What Is the Orion Oyj B Stock Price Today?
The Orion Oyj B stock price today is 42.56.
What Is the Stock Symbol for Orion Oyj B?
The stock symbol for Orion Oyj B is "ORNBV."
What Stock Exchange Does Orion Oyj B Trade On?
Orion Oyj B is listed and trades on the Helsinki stock exchange.
Is Orion Oyj B a Good Stock to Buy?
Determining whether Orion Oyj B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORNBV quote. (ISIN: FI0009014377)
What Is the Orion Oyj B Stock Price Today?
The Orion Oyj B stock price today is 42.56.
What Is the Stock Symbol for Orion Oyj B?
The stock symbol for Orion Oyj B is "ORNBV."
What Stock Exchange Does Orion Oyj B Trade On?
Orion Oyj B is listed and trades on the Helsinki stock exchange.
Is Orion Oyj B a Good Stock to Buy?
Determining whether Orion Oyj B—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ORNBV quote. (ISIN: FI0009014377)
42.56
-0.43(-1.00%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.43
43.13
52 wk Range
31.86
50.16
ORNBV Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
42.4343.13
52 wk Range
31.8650.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.81%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.81%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ORNBV Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
50.00
Upside
+17.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
- Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Orion B receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Orion Oyj B Company Profile
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson’s disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer. It also offers Salmeterol/fluticasone Easyhaler, Budesonide/formoterol Easyhaler, Formoterol Easyhaler, Budesonide Easyhaler, Beclomet Easyhaler, and Buventol Easyhaler drugs for the treatment of asthma and chronic obstructive pulmonary disease. In addition, the company provides veterinary drugs comprising Bonqat, Clevor, Domosedan, Domitor, Antisedan, Dexdomitor, Domosedan Gel, Sileo, and Tessie; APIs for generic compounds and proprietary products, as well as contract manufacturing services; and markets and sells veterinary drugs manufactured by other international companies. Further, the company has partnership with Propeller Health to connect the Easyhaler(R) product portfolio; and a research collaboration and license agreement with Amneal Pharmaceuticals, Inc. to commercialize Amneal’s generic products. Orion Oyj was founded in 1917 and is headquartered in Espoo, Finland.
Compare ORNBV to Peers and Sector
Metrics to compare | ORNBV | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipORNBVPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.2x | 19.3x | −0.6x | |
PEG Ratio | 0.20 | 0.03 | 0.00 | |
Price/Book | 6.5x | 2.2x | 2.6x | |
Price / LTM Sales | 4.2x | 2.1x | 3.2x | |
Upside (Analyst Target) | 15.1% | 26.4% | 40.6% | |
Fair Value Upside | Unlock | 16.0% | 7.1% | Unlock |
Analysts' Recommendations
4 Buy
1 Hold
1 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 50.00
(+17.48% Upside)
Dividends
Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.36
Dividend Yield
3.81%
Industry Median 4.21%
Annualised payout
1.6200
Paid unevenly
5-Years Growth
+1.55%
Growth Streak
People Also Watch
FAQ
What Is the Orion Oyj B (ORNBV) Stock Price Today?
The Orion Oyj B stock price today is 42.56
What Stock Exchange Does Orion Oyj B Trade On?
Orion Oyj B is listed and trades on the Helsinki stock exchange.
What Is the Stock Symbol for Orion Oyj B?
The stock symbol for Orion Oyj B is "ORNBV."
Does Orion Oyj B Pay Dividends? What’s The Current Dividend Yield?
The Orion Oyj B dividend yield is 3.81%.
What Is the Orion Oyj B Market Cap?
As of today, Orion Oyj B market cap is 5.97B.
What is Orion Oyj B Earnings Per Share?
The Orion Oyj B EPS is 2.36.
What Is the Next Orion Oyj B Earnings Date?
Orion Oyj B will release its next earnings report on 24 Feb 2025.
From a Technical Analysis Perspective, Is ORNBV a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.